US/EU Agreement Will Reduce Global Import Testing Burden

 
• By Bowman Cox

US drug makers will no longer have to retest batches exported to the EU under a mutual recognition agreement provision expected to take effect by July 2019. It's a landmark development in industry's quest to eliminate import testing, which it says wastes time and resources. But many nations around the world still require import testing – our interactive map shows which rules apply where.

Testing required
Despite US/EU waiver, import testing requirements persist in many countries (see interactive map below for details) • Source: IFPMA

More from Compliance

More from Pink Sheet